Related Experiment Video

Updated: Jul 4, 2026

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

Prostate cancer diagnosis: importance of individualized risk stratification models over PSA alone

Felix K-H Chun, Pierre I Karakiewicz, Alberto Briganti

    European Urology
    |June 10, 2008
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Detection and Isolation of Cancer in Prostate Biopsies Using Stimulated Raman Histology and Artificial Intelligence
    08:05

    Detection and Isolation of Cancer in Prostate Biopsies Using Stimulated Raman Histology and Artificial Intelligence

    Published on: June 10, 2025

    Enhancing Prostate Tumor Biobanking Reliability with Improved Sampling Technique and Histological Characterization
    07:34

    Enhancing Prostate Tumor Biobanking Reliability with Improved Sampling Technique and Histological Characterization

    Published on: November 17, 2023

    Related Experiment Videos

    Last Updated: Jul 4, 2026

    Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
    13:19

    Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

    Published on: November 2, 2013

    Detection and Isolation of Cancer in Prostate Biopsies Using Stimulated Raman Histology and Artificial Intelligence
    08:05

    Detection and Isolation of Cancer in Prostate Biopsies Using Stimulated Raman Histology and Artificial Intelligence

    Published on: June 10, 2025

    Enhancing Prostate Tumor Biobanking Reliability with Improved Sampling Technique and Histological Characterization
    07:34

    Enhancing Prostate Tumor Biobanking Reliability with Improved Sampling Technique and Histological Characterization

    Published on: November 17, 2023

    Related Concept Videos

    Cancer Survival Analysis01:21

    Cancer Survival Analysis

    Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

    Articles linked to this work by shared authors, journal, and citation graph.

    An Explanatory Case on the Limitations of Lymph Node Staging in Recurrent Prostate Cancer.

    Urology case reports·2017

    Obesity is associated with biochemical recurrence after radical prostatectomy: A multi-institutional extended validation study.

    Urologic oncology·2017

    Diagnostic Accuracy of 64Copper Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography for Primary Lymph Node Staging of Intermediate- to High-risk Prostate Cancer: Our Preliminary Experience.

    Urology·2017

    The Microbiome of the Prostate Tumor Microenvironment.

    European urology·2017

    Is transurethral resection alone enough for the diagnosis of histological variants? A single-center study.

    Urologic oncology·2017

    Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Primary Non-muscle-invasive Bladder Cancer.

    Clinical genitourinary cancer·2017

    Impact of Treatment Intensification with Abiraterone on Fracture-related Hospitalisation in Newly Diagnosed Prostate Cancer: A Secondary Analysis of Two Randomised Phase 3 Trials Within the STAMPEDE Trial Platform.

    European urology·2026

    Why Look Further When the Solution Is in Front of You - or Is It? The Value of Confirmatory PSA in Prostate Cancer Screening.

    European urology·2026

    Darolutamide Plus Androgen-deprivation Therapy in Metastatic Hormone-sensitive Prostate Cancer by Disease Volume and Risk Subgroups in the Phase 3 ARANOTE Trial.

    European urology·2026

    Hereditary Renal Cancer Syndromes: Redefining Clinical Management in the Era of Precision Medicine.

    European urology·2026

    PSMA Radio-guided Surgery to Identify Lymph Node Metastases in Prostate Cancer Patients Undergoing Robot-assisted Radical Prostatectomy and Extended Pelvic Lymph Node Dissection: Results of a Phase 2 Prospective Study.

    European urology·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us